Lam Kwok-Keung, Lee Yen-Mei, Hsiao George, Chen Shu-Ying, Yen Mao-Hsiung
Department of Pharmacology, Taipei Medical College, Taipei, Taiwan.
Menopause. 2006 Mar-Apr;13(2):294-302. doi: 10.1097/01.gme.0000182806.99137.5e.
We investigated whether the effect of estrogen therapy on vascular endothelial function is mediated through increasing the bioavailability of tetrahydrobiopterin (BH4) and associated antioxidant capacity in ovariectomized (Ovx) rats.
Aortas of sham-operated, Ovx, and Ovx plus estrogen therapy (Ovx + ET) female Sprague-Dawley rats were used to measure vascular reactivity. Plasma levels of nitric oxide (NO) metabolites, total antioxidant capacity, aortic superoxide anion (O2.), and BH4 contents were determined.
Vascular reactivity, assessed on isolated aortic segments, indicated that phenylephrine-induced contraction in the Ovx group was significantly greater than that in the sham and Ovx + ET groups. The vasodilator responses to acetylcholine (10 to 10 M) and L-arginine (L-Arg; 10 M) in the sham and Ovx + ET groups were significantly greater than those in the Ovx group. Pretreatment with BH4 (10 M) enhanced the vasodilator responses to L-Arg in the Ovx group compared with the untreated Ovx group. An inhibitor of BH4 synthesis, 2,4-diamino-6-hydroxypyrimidine (2 mM), significantly attenuated the vasodilator response to L-Arg in the sham and Ovx + ET groups. In addition, Ovx significantly increased O2. production in aortic tissues and decreased plasma NO metabolites levels, whereas ET significantly prevented these effects. Pretreatment with BH4 also significantly decreased aortic O2. production in the Ovx group; both plasma total antioxidant capacity and aortic BH4 contents in the Ovx group decreased significantly compared with those in the sham group, which were also improved by ET. There were no significant differences in the protein expression of endothelial NO synthase in aortas in these groups.
ET increases the availability of vascular BH4 to attenuate O2. production and restores total antioxidant capacity, leading to improved NO-mediated vasodilation in Ovx rats.
我们研究了雌激素疗法对血管内皮功能的影响是否通过增加去卵巢(Ovx)大鼠体内四氢生物蝶呤(BH4)的生物利用度及相关抗氧化能力来介导。
使用假手术、去卵巢及去卵巢加雌激素疗法(Ovx + ET)的雌性Sprague-Dawley大鼠的主动脉来测量血管反应性。测定血浆一氧化氮(NO)代谢产物水平、总抗氧化能力、主动脉超氧阴离子(O₂⁻)及BH4含量。
对分离的主动脉段进行的血管反应性评估表明,去卵巢组中苯肾上腺素诱导的收缩显著大于假手术组和去卵巢加雌激素疗法组。假手术组和去卵巢加雌激素疗法组对乙酰胆碱(10⁻¹⁰至10⁻⁶M)和L-精氨酸(L-Arg;10⁻⁴M)的血管舒张反应显著大于去卵巢组。与未处理的去卵巢组相比,用BH4(10⁻⁴M)预处理增强了去卵巢组对L-Arg的血管舒张反应。BH4合成抑制剂2,4-二氨基-6-羟基嘧啶(2 mM)显著减弱了假手术组和去卵巢加雌激素疗法组对L-Arg的血管舒张反应。此外,去卵巢显著增加了主动脉组织中O₂⁻的产生并降低了血浆NO代谢产物水平,而雌激素疗法显著预防了这些影响。用BH4预处理也显著降低了去卵巢组主动脉中O₂⁻的产生;与假手术组相比,去卵巢组的血浆总抗氧化能力和主动脉BH4含量均显著降低,雌激素疗法也改善了这些指标。这些组中主动脉内皮型一氧化氮合酶的蛋白表达无显著差异。
雌激素疗法增加了血管BH4的可用性,以减弱O₂⁻的产生并恢复总抗氧化能力,从而改善去卵巢大鼠中NO介导的血管舒张。